4.5 Article

The association between prostatitis and risk of prostate cancer: a National Health Insurance Database study

Related references

Note: Only part of the references are listed.
Editorial Material Integrative & Complementary Medicine

A brief introduction to research based on real-world evidence: Considering the Korean National Health Insurance Service database

Eun Kyoung Ahn

INTEGRATIVE MEDICINE RESEARCH (2022)

Review Urology & Nephrology

Prostate diseases and microbiome in the prostate, gut, and urine

Makito Miyake et al.

Summary: The microbiome in various organs, especially in the genitourinary system, plays a significant role in both benign and malignant diseases of the prostate. Further research is needed to explore the relationship between the urogenital microbiome and prostate pathogenesis.

PROSTATE INTERNATIONAL (2022)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Oncology

Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2018

Seri Hong et al.

Summary: The study presents national cancer statistics and trends in Korea for 2018, covering incidence, mortality, survival, and prevalence rates. Overall, cancer incidence rates increased annually by 3.3% from 1999 to 2012, then decreased by 5.4% annually from 2012 to 2015, followed by insignificant changes. Meanwhile, cancer mortality rates have been decreasing since 2002, with a more rapid decline in recent years.

CANCER RESEARCH AND TREATMENT (2021)

Article Urology & Nephrology

The presence of chronic inflammation in positive prostate biopsy is associated with upgrading in radical prostatectomy

Ekrem Guner et al.

Summary: Chronic prostatitis associated with prostate cancer may impact the Gleason score upgrade in radical prostatectomy specimens, suggesting a potential link between chronic inflammation and more aggressive tumors.

ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA (2021)

Review Oncology

Epidemiology and Prevention of Prostate Cancer

Giorgio Gandaglia et al.

Summary: Prostate cancer (PCa) rates vary profoundly worldwide, with incidence and mortality rates being highest in Northern Europe and the Caribbean, respectively. South-Central Asia has the lowest epidemiological burden. Family history, race, and hereditary syndromes are well-established risk factors for PCa. Modifiable risk factors may impact the risk of developing PCa and that of dying from the disease itself, but little evidence exists for any clear indication for prevention other than early diagnosis to reduce PCa mortality.

EUROPEAN UROLOGY ONCOLOGY (2021)

Article Andrology

Impact of Benign Prostatic Hyperplasia and/or Prostatitis on the Risk of Prostate Cancer in Korean Patients

Sung Han Kim et al.

Summary: This study evaluated the impact of BPH and prostatitis on the risk of prostate cancer in Korean men and found that patients with BPH and prostatitis had a significantly increased risk of developing prostate cancer. In particular, the risk was highest for patients with both BPH and prostatitis.

WORLD JOURNAL OF MENS HEALTH (2021)

Article Multidisciplinary Sciences

Microbiome analyses of blood and tissues suggest cancer diagnostic approach

Gregory D. Poore et al.

NATURE (2020)

Review Urology & Nephrology

The inflammatory microenvironment and microbiome in prostate cancer development

Karen S. Sfanos et al.

NATURE REVIEWS UROLOGY (2018)

Review Oncology

The microbiome in prostate inflammation and prostate cancer

Corey M. Porter et al.

PROSTATE CANCER AND PROSTATIC DISEASES (2018)

Article Urology & Nephrology

Inflammation on Prostate Needle Biopsy is Associated with Lower Prostate Cancer Risk: A Meta-Analysis

Shaleen R. Vasavada et al.

JOURNAL OF UROLOGY (2017)

Article Urology & Nephrology

Is histological prostate inflammation in an initial prostate biopsy a predictor of prostate cancer on repeat biopsy?

Bu Hyeon Yun et al.

INTERNATIONAL UROLOGY AND NEPHROLOGY (2015)

Review Oncology

Cancer-related inflammation and treatment effectiveness

Connie I. Diakos et al.

LANCET ONCOLOGY (2014)

Article Multidisciplinary Sciences

The Role of Prostatitis in Prostate Cancer: Meta-Analysis

Junyi Jiang et al.

PLOS ONE (2013)

Review Immunology

Cancer and Inflammation: An Old Intuition with Rapidly Evolving New Concepts

Giorgio Trinchieri

ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)

Review Cell Biology

Prostate cancer and inflammation: the evidence

Karen S. Sfanos et al.

HISTOPATHOLOGY (2012)

Article Oncology

Red wine consumption and risk of prostate cancer: the California men's health study

Chun Chao et al.

INTERNATIONAL JOURNAL OF CANCER (2010)

Article Pharmacology & Pharmacy

Chronic Prostatitis Management Strategies

Adam B. Murphy et al.

DRUGS (2009)

Article Infectious Diseases

Epidemiology of prostatitis

John N. Krieger et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)

Article Oncology

Gonorrhea, syphilis, clinical prostatitis, and the risk of prostate cancer

Siobhan Sutcliffe et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)

Review Multidisciplinary Sciences

Inflammation and cancer

LM Coussens et al.

NATURE (2002)

Article Urology & Nephrology

Epidemiologic association between prostatitis and prostate cancer

LK Dennis et al.

UROLOGY (2002)

Review Medicine, General & Internal

Inflammation and cancer: back to Virchow?

F Balkwill et al.

LANCET (2001)